Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (421-430 of 606) with videos related to

Pageof 61
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Oncogene|May 5, 2010
Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cellsG Guo, X Qiu, S Wang, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Pageof 61

Showing results (421-430 of 606) with videos related to

Sort By:
Pageof 61
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Oncogene|May 5, 2010
Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cellsG Guo, X Qiu, S Wang, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Pageof 61